Clinical trial
TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era
NCT05752019 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era
- Lead sponsor
- Erasmus Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 21, 2022
- Completion date
- December 31, 2024
- Enrollment
- 103 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital disorders, cystic fibrosis, exacerbation, symptom, infections, bacterial, inflammation lungs, lung disease; cystic, lung disease; cystic, congenital, lung diseases, lung infection, lung inflammation